Israeli startup seeks to boost bone renewal and allow targeted drug delivery

New peptide developed by Bone Sci Bio has shown in clinical trials to be effective in regeneration and integration with existing bone tissue; FDA still needs to approve

Israeli startup Bone Sci Bio Ltd. is developing a product that treats bones by promoting the formation and repair of their tissue.
The firm was set to present its new solution at the MIXiii-BIOMED 2019 Conference and Exhibition, taking place on May 14-16 at in Tel Aviv.
Read more: